Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,619 across all filing types
Latest filing 2017-07-04 Annual Report
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
106年年報及股東會資料 — 2017_3164_20170628F02.pdf
Annual Report Classification · 95% confidence The document is a detailed shareholder meeting manual for GenMont Biotech Inc. for the year 2016 (Republic of China calendar year 105). It includes the agenda of the Annual General Meeting (AGM), reports such as the 105th fiscal year business report, supervisory review reports, auditor's audit report, and the 105th fiscal year financial statements. The document contains comprehensive financial data, audit opinions, management reports, and governance-related appendices. The presence of the full annual business report, audited financial statements, and detailed financial analysis indicates this is the full Annual Report document rather than just an announcement or a summary. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely a notice or certification. Therefore, the appropriate classification is Annual Report (10-K). FY 2016
2017-07-04 Chinese
106年年報及股東會資料 — 2017_3164_20170628F13.pdf
AGM Information Classification · 95% confidence The document is a detailed agenda and materials for a shareholders' meeting (Annual General Meeting) of GenMont Biotech Inc. It includes meeting time, location, chairman's speech, reports on business operations, financial statements, asset impairment, election of directors and supervisors, and other shareholder meeting matters. The document is not a financial report itself but rather the information and proposals presented at the AGM. The presence of agenda items, voting proposals, and election details confirms it is AGM-related material. The document length is 2140 characters, which is relatively short and consistent with meeting materials rather than a full annual report or financial statements. Therefore, the document fits the category of AGM Information (AGM-R).
2017-07-04 Chinese
106年年報及股東會資料 — 2017_3164_20170628F01.pdf
AGM Information Classification · 95% confidence The document is a detailed notice and instructions for the 106th Annual General Meeting (股東常會) of 景岳生物科技股份有限公司, including meeting date, location, agenda items such as approval of the 105年度決算表冊 (financial statements), election of directors and supervisors, proxy instructions, and other shareholder meeting procedural details. It contains no financial statements or management discussion but is clearly a meeting notification and related materials for the Annual General Meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is sufficient and it is not merely an announcement of a report publication. Therefore, the classification is AGM-R with high confidence.
2017-07-04 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a short announcement (770 characters) from a listed company regarding its commitments and subsequent execution related to its application for stock listing transfer. It references compliance with a regulatory letter from the Taiwan Stock Exchange and discusses financial reporting commitments and their status as of a certain date. There is no detailed financial data, no full report, and the document mainly serves as a regulatory disclosure or compliance update. It is not a full Annual Report, Interim Report, or Audit Report. It is also not a report publication announcement since it contains substantive content about the commitments and their status. Given the nature and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2017-07-04 Chinese
公告本公司第二屆薪資報酬委員會委員任期屆滿
Board/Management Information Classification · 95% confidence The document is a short announcement (725 characters) about the expiration of terms for members of the company's remuneration committee. It lists names, roles, and dates related to committee membership changes. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond the announcement of management committee changes. This fits the category of Board/Management Information (MANG), as it concerns changes in company committees and management-related personnel information.
2017-06-29 Chinese
公告本公司第八屆董事會重要決議
Board/Management Information Classification · 100% confidence The document is a company announcement from the board of directors regarding an important resolution, specifically the re-election of the chairman of the board. It includes details such as the date of the event, the name of the company, and the appointment date of the new chairman. There is no financial data, no mention of a report or financial results, and it focuses solely on board/management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2017-06-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.